Search Results for: SRC

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
CUL4B cullin 4B
  • Recognition of DNA damage by PCNA-containing replication complex
  • DNA Damage Recognition in GG-NER
  • Formation of Incision Complex in GG-NER
  • Dual Incision in GG-NER
  • Formation of TC-NER Pre-Incision Complex
  • Transcription-Coupled Nucleotide Excision Repair (TC-NER)
  • Dual incision in TC-NER
  • Gap-filling DNA repair synthesis and ligation in TC-NER
  • Neddylation
  • Syndromic X-linked mental retardation, including: Turner type (MRXST); Siderius type (MRXSSD) ; Cabezas type (MRXC); Raymond type (MRXSR); Type10 (MRXS10); Type14 (MRXS14); Mental retardation with isolated growth hormone deficiency (MRGH)
DAB1 DAB adaptor protein 1
  • Reelin signalling pathway
DAB2 DAB adaptor protein 2
  • Gap junction degradation
  • Formation of annular gap junctions
  • Cargo recognition for clathrin-mediated endocytosis
  • Clathrin-mediated endocytosis
DAG1 dystroglycan 1
  • Non-integrin membrane-ECM interactions
  • ECM proteoglycans
  • ECM proteoglycans
  • Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3
  • Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2
  • Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1
  • DAG1 core M2 glycosylations
  • DAG1 core M3 glycosylations
  • DAG1 core M1 glycosylations
  • Regulation of expression of SLITs and ROBOs
  • EGR2 and SOX10-mediated initiation of Schwann cell myelination
  • Formation of the dystrophin-glycoprotein complex (DGC)
  • Formation of the dystrophin-glycoprotein complex (DGC)
  • Matriglycan biosynthesis on DAG1
  • Limb-girdle muscular dystrophy (LGMD)
DAPP1 dual adaptor of phosphotyrosine and 3-phosphoinositides 1
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Inositol 1,3,4,5-Tetrakisphosphate
DDR2 discoidin domain receptor tyrosine kinase 2
  • Non-integrin membrane-ECM interactions
  • Imatinib
  • Regorafenib
  • Fostamatinib
  • Spondylometaepiphyseal dysplasia, short limb-hand type; Spondylometaepiphyseal dysplasia, short limb-abnormal calcification type
DGKA diacylglycerol kinase alpha
  • Effects of PIP2 hydrolysis
  • Vitamin E
  • alpha-Tocopherol succinate
DGKZ diacylglycerol kinase zeta
  • Effects of PIP2 hydrolysis
  • alpha-Tocopherol succinate
DLG4 discs large MAGUK scaffold protein 4
  • Signaling by ERBB4
  • Trafficking of AMPA receptors
  • Unblocking of NMDA receptors, glutamate binding and activation
  • Unblocking of NMDA receptors, glutamate binding and activation
  • Ras activation upon Ca2+ influx through NMDA receptor
  • NrCAM interactions
  • Activation of Ca-permeable Kainate Receptor
  • RHO GTPases activate CIT
  • RAF/MAP kinase cascade
  • LGI-ADAM interactions
  • Neurexins and neuroligins
  • Neurexins and neuroligins
  • Synaptic adhesion-like molecules
  • Assembly and cell surface presentation of NMDA receptors
  • Negative regulation of NMDA receptor-mediated neuronal transmission
  • Long-term potentiation
  • Guanidine
  • Guanosine-5'-Monophosphate
DNM1 dynamin 1
  • Toll Like Receptor 4 (TLR4) Cascade
  • Retrograde neurotrophin signalling
  • Gap junction degradation
  • Formation of annular gap junctions
  • MHC class II antigen presentation
  • EPH-ephrin mediated repulsion of cells
  • Recycling pathway of L1
  • Clathrin-mediated endocytosis
DNM2 dynamin 2
  • Toll Like Receptor 4 (TLR4) Cascade
  • Retrograde neurotrophin signalling
  • Gap junction degradation
  • Formation of annular gap junctions
  • NOSTRIN mediated eNOS trafficking
  • MHC class II antigen presentation
  • Lysosome Vesicle Biogenesis
  • Golgi Associated Vesicle Biogenesis
  • Recycling pathway of L1
  • Clathrin-mediated endocytosis
  • NGF-stimulated transcription
  • Degradation of CDH1
  • Centronuclear myopathy
  • Charcot-Marie-Tooth disease (CMT); Hereditary motor and sensory neuropathy; Peroneal muscular atrophy
DOK1 docking protein 1
  • PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1
  • RET signaling
DOK2 docking protein 2
  • Tie2 Signaling
  • RET signaling
DOK4 docking protein 4
  • RET signaling
DPYD dihydropyrimidine dehydrogenase
  • Pyrimidine catabolism
  • (5S)-5-Iododihydro-2,4(1H,3H)-pyrimidinedione
  • NADPH
  • 6-Carboxymethyluracil
  • Flavin adenine dinucleotide
  • Flavin mononucleotide
  • Uracil
  • Eniluracil
  • 5-Iodouracil
  • Gimeracil
  • Tegafur-uracil
  • Dihydropyrimidine dehydrogenase deficiency
DUSP12 dual specificity phosphatase 12
EFNA5 ephrin A5
  • EPH-Ephrin signaling
  • EPH-Ephrin signaling
  • EPHA-mediated growth cone collapse
  • EPHA-mediated growth cone collapse
  • EPH-ephrin mediated repulsion of cells
  • EPH-ephrin mediated repulsion of cells
EFNB1 ephrin B1
  • EPH-Ephrin signaling
  • EPH-Ephrin signaling
  • EPHB-mediated forward signaling
  • EPHB-mediated forward signaling
  • Ephrin signaling
  • Ephrin signaling
  • EPH-ephrin mediated repulsion of cells
  • Craniosynostosis, including: Pfeiffer syndrome; Apert syndrome; Crouzon syndrome; Jackson-Weiss syndrome; Beare-Stevenson syndrome; Muenke craniosynostosis; Saethre-Chotzen syndrome; Craniosynostosis Boston type; Antley-Bixler syndrome; Carpenter syndrome; Craniofrontonasal dysplasia; Noonan syndrome; Baller-Gerold syndrome
EFNB2 ephrin B2
  • EPH-Ephrin signaling
  • EPH-Ephrin signaling
  • EPHB-mediated forward signaling
  • EPHB-mediated forward signaling
  • Ephrin signaling
  • Ephrin signaling
  • EPH-ephrin mediated repulsion of cells
EFS embryonal Fyn-associated substrate

Page 20 out of 32 pages